Genes to mental health (g2mh) / Sébastien Jacquemont en The American Journal of Psychiatry, Año 2022 Vol. 179 - No. 3 (Marzo)

Público ISBD [artículo]  inThe American Journal of Psychiatry > Año 2022 Vol. 179 - No. 3 (Marzo) . - pp. 189-203 Título : Genes to mental health (g2mh) : a framework to map the combined effects of rare and common variants on dimensions of cognition and psychopathology Tipo de documento: texto impreso Autores: Sébastien Jacquemont, Autor ; Guillaume Huguet, Autor ; Marieke Klein, Autor Fecha de publicación: 2022 Artículo en la página: pp. 189-203 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Genética - genómica, Trastornos del neurodesarrollo, Espectro de esquizofrenia y otros trastornos psicóticos, Trastorno del espectro autista, Discapacidades intelectuales, Diagnóstico y Clasificación. Resumen: Rare genomic disorders (RGDs) confer elevated risk for neurodevelopmental psychiatric disorders. In this era of intense genomics discoveries, the landscape of RGDs is rapidly evolving. However, there has not been comparable progress to date in scalable, harmonized phenotyping methods. As a result, beyond associations with categorical diagnoses, the effects on dimensional traits remain unclear for many RGDs. Link: ./index.php?lvl=notice_display&id=28397 [artículo] Genes to mental health (g2mh) : a framework to map the combined effects of rare and common variants on dimensions of cognition and psychopathology [texto impreso] / Sébastien Jacquemont, Autor ; Guillaume Huguet, Autor ; Marieke Klein, Autor . - 2022 . - pp. 189-203. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The American Journal of Psychiatry > Año 2022 Vol. 179 - No. 3 (Marzo) . - pp. 189-203 Palabras clave: Genética - genómica, Trastornos del neurodesarrollo, Espectro de esquizofrenia y otros trastornos psicóticos, Trastorno del espectro autista, Discapacidades intelectuales, Diagnóstico y Clasificación. Resumen: Rare genomic disorders (RGDs) confer elevated risk for neurodevelopmental psychiatric disorders. In this era of intense genomics discoveries, the landscape of RGDs is rapidly evolving. However, there has not been comparable progress to date in scalable, harmonized phenotyping methods. As a result, beyond associations with categorical diagnoses, the effects on dimensional traits remain unclear for many RGDs. Link: ./index.php?lvl=notice_display&id=28397

---

1 (1 - 1 / 1)